Showing results (201-210 of 237) with videos related to
Sort By:
Pageof 24
Pharmacological Research|December 29, 2022
Mangosteen for malignancy prevention and intervention: Current evidence, molecular mechanisms, and future perspectivesLindsay S Kalick, Hamaad A Khan, Erica Maung, et al.Cell Death & Disease|August 7, 2015
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenograftsM N Washington, G Suh, A F Orozco, et al.Molecular Pharmacology|November 28, 2001
ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporterB N Atkinson, S C Bell, M De Vivo, et al.Scientific Reports|March 1, 2022
Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot studySusanne M Cabrera, Alison T Coren, Tarun Pant, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
New tumor markers: CA125 and beyondR C Bast, D Badgwell, Z Lu, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
A pilot study for a screening trial of cervical fluorescence spectroscopyA Nath, K Rivoire, S Chang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasiaS Eva Singletary, Edward N Atkinson, Ashraful Hoque, et al.Journal of Medicinal Chemistry|December 23, 2021
Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar ActivityDavid Steadman, Benjamin N Atkinson, Yuguang Zhao, et al.Medchemcomm|September 20, 2019
Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screenBenjamin N Atkinson, David Steadman, Yuguang Zhao, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2019
Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitorsBenjamin N Atkinson, David Steadman, William Mahy, et al.Pageof 24